Awards

Presidents Circle Laurel Pin - 2024

Benefactor

Bicentennial Medal - 2019

About Robert L. Zerbe

Robert L. Zerbe received an undergraduate degree from Indiana University, an MD from Indiana University School of Medicine, and completed post-doctoral work in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Health. Zerbe is currently a member of IU Foundation’s Board of Directors.

Zerbe is the co-founder, CEO, and director of Quatrx Pharmaceuticals. He has extensive experience in general management, global clinical research and development, clinical trial design and management, and regulatory affairs with major pharmaceutical companies. Zerbe has served as a member of development teams that have produced nine different drugs, including Lipitor and Prozac, which generated sales in excess of one billion dollars. Prior to Quatrx, Zerbe served in numerous senior executive management positions with pharmaceutical companies including Eli Lilly and Company, and as Pfizer managing director, Lilly Research Center U.K., and vice president of clinical investigation and regulatory affairs. He joined Parke-Davis in 1993, becoming senior vice president of worldwide clinical research and development.

Zerbe serves on the board of directors for many prestigious companies, including Cirius Therapeutics, Indiana University Foundation, Vericel Corporation, and Metabolic Solutions Development Company, LLC. Zerbe is a fellow of the American College of Physicians. In 2019, Zerbe received Indiana University’s Bicentennial Medal, in recognition of his distinguished contributions and support of the university.